How Do You Get Tested for an STD: What to Expect

STD testing typically involves providing a urine sample, having blood drawn, or swabbing the genitals, throat, or rectum, depending on which infections your provider is checking for. There is no single “full panel” test that catches everything at once, so what happens during your visit depends on your sexual history, symptoms, and risk factors. The process is usually quicker and less uncomfortable than most people expect, but a few details about timing, specimen types, and accuracy are worth knowing before you walk in.

Why Testing Matters When You Feel Fine

One of the biggest misconceptions about STDs is that you would know if you had one. For chlamydia and gonorrhea, the two most commonly reported bacterial infections, the majority of cases produce no symptoms at all. A screening study estimated that roughly 77% of chlamydia infections and 45% of gonorrhea infections never caused symptoms, and that nearly all untreated cases went untreated specifically because the person never felt anything wrong.¹ That means waiting for a burning sensation or unusual discharge before getting tested leaves the vast majority of infections undetected. Those silent infections can still cause complications like pelvic inflammatory disease or infertility, and they can still be passed to partners. Routine screening is the only reliable way to catch them.

What Specimens You Will Provide

The type of sample collected depends on the infection being tested for. For most people, a visit will involve some combination of these:

Urine sample: Used to screen for chlamydia, gonorrhea, and sometimes trichomonas. You urinate into a cup, and no swabbing is required. Clinics usually ask you not to urinate for at least an hour before the test so the sample contains enough organisms to detect.
Vaginal swab: For people with vaginas, a swab of the vaginal wall is the most sensitive specimen type for chlamydia, gonorrhea, and trichomoniasis. A meta-analysis found vaginal swabs caught about 94% of chlamydia cases compared to about 87% for urine, and roughly 97% of gonorrhea compared to about 91% for urine.² If your clinic offers it, the vaginal swab is the better option.
Blood draw: Used for HIV, syphilis, and hepatitis B and C. A standard venous blood draw or sometimes a finger prick, depending on the test.
Throat or rectal swab: Used for people who have had oral or anal sex, to check for chlamydia and gonorrhea at those sites. These are quick swabs that take just a few seconds.

Self-Collected Swabs Are Just as Good

If the idea of a clinician-collected swab makes you nervous, there is good news. Many clinics now let you collect your own vaginal swab in a private room. A systematic review and meta-analysis found that self-collected vaginal swabs had about 92% sensitivity for chlamydia, with 98% specificity, compared to clinician-collected cervical swabs.³ For practical purposes, the results are comparable. Self-collection also tends to make people more comfortable and more willing to get tested in the first place, which matters more than a small difference in sensitivity.

Why Throat and Rectal Swabs Are Not Optional

Standard urine or genital testing misses infections at other body sites. Chlamydia and gonorrhea can infect the throat and rectum independently, and those infections often exist without any genital infection at all. A study using PCR testing found that among women with chlamydia, 13% of infections were detected only by testing a rectal or throat swab, not by the genital specimen. Among men who have sex with men, two-thirds of infections were caught only by the rectal swab.⁴ Extragenital sites act as hidden reservoirs that can quietly sustain transmission even after genital infections are treated.⁵ If you have had oral or anal sex and your provider only orders a urine test, it is worth asking about throat and rectal swabs.

When to Get Tested After Exposure

Every STD has a “window period,” the gap between when you are exposed and when a test can reliably detect the infection. Testing too soon after a potential exposure can give you a false negative. The window varies by infection:

Chlamydia and gonorrhea: Detectable about one to two weeks after exposure using nucleic acid amplification tests (NAATs). Testing before that may miss a new infection.
Syphilis: Blood tests typically become positive about three to six weeks after exposure, though the timing depends on the stage and the type of test used.
HIV: The window depends heavily on the test type. Fourth-generation lab tests that detect both antigen and antibody have a median window of about 18 days, with virtually all infections detectable by about 44 days.⁶ Older third-generation tests that detect only antibodies have a longer median window of around 22 days.⁷
Hepatitis B and C: Antibody tests may take several weeks to months. Hepatitis C antibody tests can take up to three months to turn positive.

If you test negative within the window period after a known exposure, your provider will likely recommend retesting once the window has passed. A negative result taken three days after unprotected sex tells you very little.

HIV Testing in More Detail

HIV testing deserves its own discussion because the technology has changed significantly. The current standard in clinical labs is a fourth-generation test that looks for both HIV antibodies and a viral protein called p24 antigen. Adding antigen detection shortens the window period compared to antibody-only tests. Fourth-generation rapid tests used in clinic or community settings also detect both markers. A study of two such rapid tests found that none were reactive in the first two weeks after infection, but by three weeks post-infection, both reached 100% sensitivity.⁸

There is a quirk worth knowing about, though. In rare cases, a fourth-generation test can actually produce a negative result during a “second diagnostic window.” This happens when the initial p24 antigen spike fades but antibodies have not yet risen high enough to trigger the test. One documented case showed this second gap lasting 18 to 34 days on a fourth-generation test.⁹ This is uncommon, but it underscores why clinicians sometimes order follow-up testing if they strongly suspect a recent exposure despite a negative screen.

Point-of-care nucleic acid tests are also emerging for HIV. One real-world evaluation in China found that a point-of-care nucleic acid test had nearly 99% sensitivity for acute HIV infection and cut the median time from screening to results in half compared to standard laboratory-based testing.¹⁰ These are not yet widely available everywhere, but the trend is toward faster and more accessible HIV diagnostics.

Why Herpes Testing Is Handled Differently

If you ask for a “full STD panel,” herpes testing is usually not included, and that is intentional. The US Preventive Services Task Force specifically recommends against routine herpes blood testing in people without symptoms. The reason is not that herpes does not matter; it is that the most widely used blood test for HSV-2 has a high false-positive rate, particularly in populations where herpes is less common. Confirmatory testing is not widely available, and a false diagnosis can cause significant psychological distress without any clinical benefit.¹¹

The evidence review behind that recommendation found that the test’s specificity varied substantially across studies, and in populations with lower herpes prevalence, the proportion of false positives climbs steeply. Cross-reactivity with HSV-1, geographic variation in HSV-2 strains, and recent seroconversion all contribute to inaccurate results. Two observational studies also documented that unexpected positive results from screening led to anxiety, worry, and distress, even when the result may not have been accurate.¹² Additionally, HSV-1 serologic tests cannot tell you whether the infection is oral or genital, so a positive HSV-1 blood test in someone who has had cold sores since childhood provides no useful information about genital herpes status.

If you have active sores or blisters, the situation is different. A provider can swab the lesion directly and send it for PCR testing or viral culture, which is much more accurate than blood testing for diagnosing an active outbreak. So the takeaway is not that herpes cannot be tested for, but that blood-based screening in people without symptoms does more harm than good with current technology.

Syphilis Has Its Own Diagnostic Complexity

Syphilis testing uses a two-step process, and clinics may use one of two approaches. The traditional algorithm starts with a nontreponemal screening test (like RPR or VDRL) and confirms positives with a treponemal test. The reverse algorithm flips that order, starting with a treponemal-specific test. A study comparing the two found that the traditional algorithm missed about 35% of syphilis diagnoses that the reverse algorithm caught, while the traditional approach also had a higher screening false-positive rate of about 7% compared to less than 1% for the reverse method.¹³ Many labs have shifted to the reverse algorithm in recent years. As a patient, you do not need to know which algorithm your lab uses, but you should know that syphilis testing sometimes requires more than one blood draw, and that a positive screen usually leads to a confirmatory test before treatment begins.

False Positives and What Low Prevalence Means for Your Results

No test is perfect, and one of the least intuitive aspects of STD testing is that even a very accurate test can produce a surprisingly high rate of false positives when the infection is rare in the population being screened. A study of gonorrhea screening using a NAAT found that in a population where only about 1% of tests came back positive, the positive predictive value of the test was just 60%. That means four out of ten positive gonorrhea results were false positives.¹⁴ This is not because the test is bad. It is because when few people in the tested group actually have the infection, even a small false-positive rate generates a lot of incorrect results relative to the true ones.

For HIV, the stakes of a false positive are especially high, and sequential testing algorithms are designed to catch them. In settings with low HIV prevalence, a single reactive screening test is never treated as a final diagnosis. Confirmatory testing reduces misdiagnosis substantially. One hospital’s refined sequential testing algorithm was able to identify false-positive results and reduce inconclusive diagnoses from 45 down to 1 adult case compared to the national guideline approach.¹⁵ If you receive a preliminary positive result for any STD, confirmatory testing is standard practice, and a positive screen is not the same as a confirmed diagnosis.

At-Home Testing Kits

At-home STD test kits, where you collect your own specimens and mail them to a lab, have become widely available. The question most people have is whether the results are trustworthy. The evidence is reassuring. A systematic review comparing specimens self-collected at home to specimens collected in a clinic found high concordance for both chlamydia and gonorrhea. For chlamydia, agreement between home and clinic specimens was about 99% for vaginal swabs and urine. For gonorrhea, concordance reached 100% for urine samples. Even rectal and throat swabs self-collected at home showed strong agreement with clinic-collected specimens, with concordance rates above 95% across multiple studies.¹⁶

Home testing removes several barriers, particularly for people who avoid clinics because of scheduling, transportation, or discomfort with the clinical setting. One potential drawback is follow-up. If your results come back positive, you still need to see a provider to get treated, and some people who test positive at home do not follow through on treatment due to fear of disclosure or stigma.¹⁷ Home kits are a good screening tool, but they are the beginning of the process, not the end.

Rapid Point-of-Care Tests and Same-Day Results

Standard laboratory-based STD tests typically take one to several days for results. Rapid point-of-care tests aim to give you an answer during the same visit so treatment can start immediately. For chlamydia and gonorrhea, a newer point-of-care device evaluated in an emergency department produced results in an average of about 29 minutes, compared to an average of over 22 hours in the central lab, a 98% reduction in turnaround time.¹⁸ Same-visit diagnosis and treatment is the goal because it eliminates the risk that someone receives a positive result days later but never returns for treatment.

Rapid HIV tests, including the OraQuick oral swab, can give a preliminary result in about 20 minutes. Rapid syphilis tests also exist, though they are used more widely in resource-limited settings than in U.S. clinics. Point-of-care testing for STDs is an active area of development, with new platforms targeting simultaneous detection of multiple pathogens from a single sample.¹⁹

Stigma as the Biggest Practical Barrier

The physical process of STD testing is straightforward: pee in a cup, get a swab, have blood drawn. For most people, the harder part is walking through the door. Stigma is consistently identified as one of the primary reasons people delay or avoid testing. A scoping review of college students found that fear of judgment, concern about social consequences, worry about parents finding out, and misconceptions about STDs all deterred students from using conventional testing facilities.²⁰

The reality is that STD testing is routine medical care. Clinicians in sexual health clinics do this all day, and nothing about your visit will surprise or shock them. If a traditional clinic feels uncomfortable, alternatives like home testing kits, telehealth-ordered tests, or community health events offer lower-visibility options. The cost of avoidance, both to your own health and to partners you might unknowingly expose, is far higher than any momentary awkwardness.

What Happens After a Positive Result

If a test comes back positive for a bacterial infection like chlamydia or gonorrhea, treatment is usually straightforward: a course of antibiotics, often a single dose. You will be advised to abstain from sex for a period (typically seven days) and to notify recent sexual partners so they can be tested and treated.

Partner notification can feel daunting, and a practice called expedited partner therapy (EPT) exists to help. With EPT, a provider gives you medication or a prescription to deliver directly to your partner without requiring that partner to come in for their own visit. Controlled trials have shown that EPT increases the rate at which partners actually get treated, and modeling suggests that providing EPT to just 20% of people diagnosed with gonorrhea or chlamydia could avert about 27% of expected STD cases over a decade in certain populations.²¹ EPT is legal in most U.S. states for chlamydia and gonorrhea, though concerns about antibiotic-resistant gonorrhea may limit its future applicability for that infection.²²

The Cost Question

Cost is a real concern, especially for people without insurance. Under the Affordable Care Act, most private insurance plans are required to cover STD screening without a copay when it is considered preventive care, though what qualifies as “preventive” varies by age, sex, and risk group. For uninsured patients, community health centers and local health departments often offer free or reduced-cost testing. One cost analysis of a safety-net STD clinic estimated that the average operating cost per visit was about $119, with lab testing and staff salaries each making up about 44% of that cost. Only about 28% of visits at that clinic used insurance, meaning the majority of patients were seen regardless of coverage.²³ If cost is a barrier, searching for your local health department’s STD clinic or a federally qualified health center is the best first step.

Testing for Less Common Infections

Most standard panels focus on the “big five”: chlamydia, gonorrhea, syphilis, HIV, and hepatitis. But other sexually transmitted organisms exist and sometimes warrant testing. Trichomonas vaginalis is the most common curable STD worldwide, yet it is not always included in routine panels. One study found that even among women who reported no symptoms, trichomoniasis was present in about 6% of cases, meaning it would have been missed entirely if those women had been triaged to a testing-only visit without an exam.²⁴

Mycoplasma genitalium is another organism gaining attention. It can cause urethritis, cervicitis, and pelvic inflammatory disease, and it is increasingly recognized as a significant pathogen. Nucleic acid amplification testing has made accurate diagnosis possible, and guidelines are evolving to integrate antibiotic resistance testing into treatment decisions for this organism.²⁵ If you have symptoms that do not match a standard diagnosis, or if you have been treated for chlamydia or gonorrhea but symptoms persist, ask your provider about testing for these less common infections. Not every clinic routinely offers it, but the tests exist and are increasingly accessible.